دورية أكاديمية

The Short-Term Safety Evaluation of Corneal Crosslinking Agent-Genipin.

التفاصيل البيبلوغرافية
العنوان: The Short-Term Safety Evaluation of Corneal Crosslinking Agent-Genipin.
المؤلفون: Song, Wenjing, Tang, Yun, Qiao, Jing, Li, Haili, Rong, Bei, Yang, Songlin, Wu, Yuan, Yan, Xiaoming
المصدر: Ophthalmic Research; 2019, Vol. 62 Issue 3, p141-149, 9p
مصطلحات موضوعية: ENDOTHELIAL cells, STAINS & staining (Microscopy), TRANSMISSION electron microscopy, CONFOCAL microscopy, ELECTRON microscopy, CORNEAL transplantation, CORNEAL topography
مستخلص: Background: Genipin (GP) is a safe method for corneal crosslinking, even for very thin corneas. However, there have been no reports on the optimal GP concentration range to use in vivo for corneal crosslinking. Objectives: To investigate the safety of corneal crosslinking after a 24-h incubation with different concentrations of GP. Methods: Twenty New Zealand white rabbits were divided into a phosphate-buffered saline (PBS) group, 0.2% GP crosslinking (GP-CXL) group, 0.25% GP-CXL group, and 0.3% GP-CXL group. Before and after surgery, the operated eyes of each group were characterized by confocal microscopy, and corneal buttons were excised for endothelium staining and electron microscopy. Results: The keratocyte structures in each GP group appeared to be similar to those in the PBS group. Through the confocal microscopy, the changes in corneal endothelial cell density also did not significantly differ among groups. There was a significant difference in apoptosis between the 0.3% GP-CXL and PBS groups (p < 0.05) and between the 0.3% GP-CXL and 0.25% GP-CXL groups (p < 0.05), but there were no significant differences between the 0.2 and 0.25% GP-CXL groups compared to the PBS group. Transmission electron microscopy showed endothelial cell damage in the 0.3% GP-CXL group, with minimal endothelial cell damage in the other groups. Conclusions: Treatment of rabbit corneas with ≤0.25% GP resulted in minimal toxicity to keratocytes and endothelial cells, suggesting that it is a safe crosslinking agent at those concentrations. [ABSTRACT FROM AUTHOR]
Copyright of Ophthalmic Research is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00303747
DOI:10.1159/000499571